Mostrar el registro sencillo del ítem
Genomic variants association with selective hypersensitivityreactions to amoxicillin and clavulanic acid
dc.contributor.author | Nuñez, Rafael | |
dc.contributor.author | Fernández-Santamaría, Rubén | |
dc.contributor.author | Salas, María | |
dc.contributor.author | Bogas, Gador | |
dc.contributor.author | Diez-Echave, Patricia | |
dc.contributor.author | Mayorga Mayorga, Cristobalina | |
dc.contributor.author | Torres-Jaén, María Josefa | |
dc.contributor.author | Fernández-Duarte, Tahía Diana | |
dc.date.accessioned | 2024-07-08T10:23:05Z | |
dc.date.available | 2024-07-08T10:23:05Z | |
dc.date.issued | 2024-06-29 | |
dc.identifier.citation | Nuñez, R., Fernandez-Santamaria, R., Salas, M., Bogas, G., Diez-Echave, P., Mayorga, C., Torres, M.J. and Fernandez, T.D. (2024), Genomic variants association with selective hypersensitivity reactions to amoxicillin and clavulanic acid. Allergy. | es_ES |
dc.identifier.uri | https://hdl.handle.net/10630/31960 | |
dc.description.abstract | In summary, there are rare variants found in our patients that could be related to the development of AX or CLV- induced IDHRs. Interestingly, some of these rare variants could be associated with selective response to AX, such as the proapoptotic endonuclease ENDOG and neutrophil degranulation pathway, previously associ- ated with drug- induced anaphylaxis,6 or to CLV, like immunoprote- asome component PSMD8. Differences could be related to nature and metabolic characteristics of each drug; however, more research is needed. These findings represent a first step to identify potential genetic biomarkers to predict the susceptibility of suffering AX and CLV IDHRs. | es_ES |
dc.description.sponsorship | This work has been supported by Institute of Health ‘Carlos III’ (ISCIII) of the Ministry of Economy and Competitiveness (MINECO), (grants co- funded by European Regional Development Fund: PI15/01206, PI17/01237, PI18/00095, PI20/01734, PI21/0329, RETICS ARADYAL RD16/0006/0001, RICORS REI, RD21/0002/0008); Andalusian Regional Ministry of Health (grants PI- 0241- 2016, PE- 0172- 2018, PI- 0127- 2020). GB is a Clinical Investigator (B- 0007- 2022) re- search contract by Andalusian Regional Ministry Health. PDE holds a Sara Borrell research contract by Institute of Health ‘Carlos III’ (CD22/00112). CM holds a ‘Nicolas Monardes’ research contract by Andalusian Regional Ministry Health (RC- 0004- 2021). Funding for open access charge: Univesidad de Malaga/CBUA. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Wiley | |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject | Alergia | es_ES |
dc.subject.other | Genomic variants | es_ES |
dc.subject.other | Hypersensitivity reactions | es_ES |
dc.subject.other | Amoxicillin | es_ES |
dc.subject.other | Clavulanic acid | es_ES |
dc.title | Genomic variants association with selective hypersensitivityreactions to amoxicillin and clavulanic acid | es_ES |
dc.type | journal article | es_ES |
dc.centro | Facultad de Medicina | es_ES |
dc.identifier.doi | https://doi.org/10.1111/all.16229 | |
dc.type.hasVersion | VoR | es_ES |
dc.departamento | Medicina y Dermatología | |
dc.rights.accessRights | open access | es_ES |